Login to Your Account



Axis teams up with Plantform to help developing countries benefit from biologics

By Oliver Griffin
Contributing Writer

Tuesday, August 22, 2017

BUENOS AIRES, Argentina – Plantpraxis – a melding of Axis Biotech Brasil, of Rio de Janeiro, and Canadian biotech Plantform Corp. – is on track to dent the costs of expensive biologic treatments in developing countries, according to Axis CEO Eduardo Cruz.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription